New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification - Top-Institutions - MDSpire

New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification

  • By

  • Encheng Li

  • Manying Shi

  • Shixiang Huang

  • June 19, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital and Brigham and Women’s Hospital (Mass General Brigham)
    Massachusetts General Hospital and Brigham and Women’s Hospital (Mass General Brigham)

    Boston, Massachusetts

    Key Differentiators

    • Allergy and Immunology

  • #2

    Johns Hopkins University School of Medicine (Johns Hopkins Asthma & Allergy Center)
    Johns Hopkins University School of Medicine (Johns Hopkins Asthma & Allergy Center)

    Baltimore, Maryland

    Key Differentiators

    • Allergy and Immunology

  • #3

    West China Second University Hospital
    West China Second University Hospital

    Chengdu, Sichuan

    Key Differentiators

    • Allergy and Immunology

Original Source(s)

New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification

  • by Encheng Li, Manying Shi, Shixiang Huang

  • June 19, 2026

Related Content

Omalizumab for severe IgE-mediated food allergy and severe asthma after pediatric liver transplantation: a case report

Non-invasive ventilation in severe acute respiratory failure complicating Madelung’s disease: a case series and management review

Effect of physical activity on pulmonary function and quality of life in asthma patients: a systematic review and meta-analysis